Older people living in long-term care facilities often have multimorbidity, requiring many prescription medicines. However, polypharmacy in older people is also associated with hospitalisations, adverse drug events, drug–drug interactions, drug– disease interactions, falls, impaired functional capacity and cognitive impairment. This article suggests that reducing polypharmacy may reduce adverse events and maintain quality of life.